Publication | Closed Access
Pharmacokinetics, metabolism and urinary detection time of flunixin after intravenous administration in camels
34
Citations
20
References
1998
Year
Intravenous AdministrationPharmacological StudyBioanalysisTandem Mass SpectrometryToxicologyClinical ChemistryAnimal PhysiologyNeutral LossMetabolomicsExperimental ToxicologyPharmacologyUrinary Detection TimeGas Chromatography/mass SpectrometryPhysiologyVeterinary ScienceClinical PharmacologyMetabolismMedicinePharmacokineticsDrug Analysis
The pharmacokinetics of flunixin were determined after an intravenous dose of 1.1 mg/kg body weight in six camels and 2.2 mg/kg body weight in four camels. The data obtained (mean +/- SEM) for the low and high dose, respectively, were as follows: The elimination half-lives (t1/2 beta) were 3.76 +/- 0.24 and 4.08 +/- 0.49 h, the steady state volumes of distribution (Vdss) were 320.61 +/- 38.53 and 348.84 +/- 35.36 mL/kg body weight, total body clearances (ClT) were 88.96 +/- 6.63 and 84.86 +/- 4.95 mL/h/kg body weight and renal clearances (Clr) were 0.52 +/- 0.09 and 0.62 +/- 0.18 mL/h/kg body weight. A hydroxylated metabolite of flunixin was identified by gas chromatography/mass spectrometry (GC/MS) under electron and chemical ionization and its major fragmentation pattern was verified by tandem mass spectrometry (GC/MS/MS) using neutral loss, daughter and parent scan modes. The detection times for flunixin and its hydroxylated metabolite in urine after an intravenous (i.v.) dose of 2.2 mg/kg body weight were 96 and 48 h, respectively.
| Year | Citations | |
|---|---|---|
Page 1
Page 1